Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR1 | Q9Y271 | 12/20 | 0.47 |
| ▸ | GPBAR1 | Q8TDU6 | 5/20 | 0.47 |
| ▸ | CYSLTR2 | Q9NS75 | 8/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4848359 | 0.98 | CYSLTR1 (0.50) | CYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL4850064 | 0.97 | CYSLTR1 (0.49) | CYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL27557740 | 0.94 | CYSLTR1 (0.44) | CYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL27558202 | 0.91 | CYSLTR1 (0.47) | CYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL27578321 | 0.91 | CYSLTR1 (0.46) | CYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL4844970 | 0.89 | CYSLTR1 (0.50) | CYSLTR1GPBAR1CYSLTR2CYP1A2 | |
| SCHEMBL14045446 | 0.88 | CYSLTR1 (0.43) | CYSLTR1GPBAR1CYSLTR2CYP1A2 | |
| SCHEMBL14021730 | 0.87 | MAPT (0.42) | CYSLTR1GPBAR1CYSLTR2CYP1A2 | |
| SCHEMBL4848684 | 0.87 | CYSLTR1 (0.46) | CYSLTR1GPBAR1CYSLTR2CYP1A2 | |
| SCHEMBL4848377 | 0.87 | CYSLTR1 (0.53) | CYSLTR1GPBAR1CYSLTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE40558-E1 | Therapeutic uses of di-aryl acid derivatives | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-10-28 | — | — | US | claimed |
| US-RE40558-E1 | Therapeutic uses of di-aryl acid derivatives | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-10-28 | — | — | US | disclosed |
| US-RE40558-E1 | Therapeutic uses of di-aryl acid derivatives | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-10-28 | — | — | US | disclosed |
| US-RE40558-E1 | Therapeutic uses of di-aryl acid derivatives | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-10-28 | — | — | US | disclosed |
| CN-101070316-A | Diaryl acid derivatives as PPAR receptor ligands | AVENTIS PHARMA GMBH (DE) | 2007-11-14 | — | — | CN | disclosed |
| CN-1331862-C | Diaryl acid derivatives as PPAR receptor ligands | AVENTIS PHARAMCEUTICALS PRODUC (DE) | 2007-08-15 | — | — | CN | disclosed |
| EP-1177187-B1 | DI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2007-07-25 | — | — | EP | disclosed |
| US-6635655-B1 | Agonists or antagonists of peroxisome proliferator-activated receptors | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-10-21 | — | — | US | disclosed |